Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment.
Schlaich
Markus P
MP
Lambert
Elisabeth A
EA
Sobotka
Paul A
PA
Lambert
Gavin W
GW
Esler
Murray D
MD
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy*; D007674:Kidney Diseases / Q000209:etiology* / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors